John Driskell Hopkins on new song and $3 million donation for ALS research
After his ALS diagnosis, Zac Brown Band's John Driskell Hopkins plans to donate $3 million to fund research through his "Hop ...
CBS News on MSN9h
John Driskell Hopkins announces $3 million donation for ALS research and coping with his diagnosis: "I am going to sing through it"
Grammy winner John Driskell Hopkins, known as "Hop" from the Zac Brown Band, is turning his personal battle with amyotrophic ...
FierceBiotech1d
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
STAT2d
Fueled by a ‘fall off your chair’ discovery and $101 million, Trace launches to take on ALS
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...
USA Today1d
Rock stars set to play Light of Day’s 25th anniversary Bob's Birthday Bash
Funds raised aid in the battle against Parkinson's Disease and the related ALS (Amyotrophic Lateral Sclerosis) and PSP ...
Key pathway leading to neurodegeneration in early stages of ALS identified
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
Business Wire1d
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...
'We’re here to keep up the fight': Idaho Pizza Company ALS fundraiser
Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...
BioTechniques1d
Protein aggregation pathway uncovered in ALS
Researchers from the University of California – San Diego (CA, USA) have worked backwards, identifying the pathway leading to ...
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage ...
Business Insider19h
Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
In October, Clene presented the design for RESTORE-ALS, its potentially confirmatory international Phase 3 clinical trial of CNMAu8 30 mg, at the 2024 Annual Northeast Amyotrophic Lateral Sclerosis ...